Trial Profile
Severe Pneumonia after a 13-Prevalent Pneumonoccal Conjugate Vaccine (Prevena 13) Among Patients with Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jan 2016
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 29 Jan 2016 New trial record